EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis

Da-Long He, Xiao-Yu Zhang, Jing-Yang Su, Qi Zhang, Ling-Xiao Zhao, Ting-Yao Wu, Hang Ren, Rong-Jun Jia, Xian-Fang Lei, Wen-Jia Hou, Wen-Ge Sun, Yong-Gang Fan und 1 weitere

Aging Cell · 2025

DOI: 10.1111/acel.14336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Da-Long He und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Hea…. Hauptthemen laut MEDLINE: Tauopathies, Exocytosis, Glycogen Synthase Kinase 3. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Science and Technology Program of Liaoning Province, The Liaoning Science and Technology Innovation Leading Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycogen synthase kinase‐3α/β (GSK3α/β) is a critical kinase for Tau hyperphosphorylation which contributes to neurodegeneration. Despite the termination of clinical trials for GSK3α/β inhibitors in Alzheimer's disease (AD) treatment, there is a pressing need for novel therapeutic strategies targeting GSK3α/β. Here, we identified the compound AS1842856 (AS), a specific forkhead box protein O1 (FOXO1) inhibitor, reduced intracellular GSK3α/β content in a FOXO1‐independent manner. Specifically, AS directly bound to GSK3α/β, promoting its translocation to the multivesicular bodies (MVBs) and accelerating exocytosis, ultimately decreasing intracellular GSK3α/β content. Expectedly, AS treatment effectively suppressed Tau hyperphosphorylation in cells exposed to okadaic acid or expressing the Tau P301S mutant. Furthermore, AS was visualized to penetrate the blood–brain barrier (BBB) using an imaging mass microscope. Long‐term treatment of AS enhanced cognitive function in P301S transgenic mice by mitigating Tau hyperphosphorylation through downregulation of GSK3α/β expression in the brain. Altogether, AS represents a novel small‐molecule GSK3α/β inhibitor that facilitates GSK3α/β exocytosis, holding promise as a therapeutic agent for GSK3α/β hyperactivation‐associated disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TauopathiesExocytosisGlycogen Synthase Kinase 3AnimalsMiceHumansGlycogen Synthase Kinase 3 betaMice, Transgenictau ProteinsPhosphorylation

Stichwörter der Autor:innen

AS1842856Tau hyperphosphorylationexocytosisglycogen synthase kinase‐3α/βneurodegenerative diseases

Substanzen

Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betatau Proteins

Autor:innen und Institutionen

  • Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Shenyang, China.
  • CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
  • First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Department of Radiology, The First Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Zhan-You Wang

Förderung

  • The National Natural Science Foundation of China
  • The Science and Technology Program of Liaoning Province
  • The Liaoning Science and Technology Innovation Leading Talent Project
  • National Natural Science Foundation of China

Zitieren

APA

He, D. L., Zhang, X. Y., Su, J. Y., Zhang, Q., Zhao, L. X., Wu, T. Y., Ren, H., Jia, R. J., Lei, X. F., Hou, W. J., Sun, W. G., Fan, Y. G., & Wang, Z. Y. (2025). Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis. Aging Cell. https://doi.org/10.1111/acel.14336

Vancouver

He DL, Zhang XY, Su JY, Zhang Q, Zhao LX, Wu TY, et al. Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis. Aging Cell. 2025. doi:10.1111/acel.14336

BibTeX
@article{He2025,
  author = {He, Da-Long and Zhang, Xiao-Yu and Su, Jing-Yang and Zhang, Qi and Zhao, Ling-Xiao and Wu, Ting-Yao and Ren, Hang and Jia, Rong-Jun and Lei, Xian-Fang and Hou, Wen-Jia and Sun, Wen-Ge and Fan, Yong-Gang and Wang, Zhan-You},
  title = {Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.14336}
}
Kostenlos starten →